Literature DB >> 32426224

Efficacy of abdominal massage with mastic gum oil on gastroesophageal reflux disease symptoms of infant: a randomized controlled trial.

Hoorieh Mohammadi Kenari1,2, Mansureh Akhavan1,2,3, Mahnaz Sadeghian4, Ali Ghobadi1,2, Shahrbanoo Nakhaie5, Zahra Rampisheh6,7, Nasrin Khalessi8.   

Abstract

Entities:  

Year:  2020        PMID: 32426224      PMCID: PMC7225736          DOI: 10.1016/j.imr.2020.02.004

Source DB:  PubMed          Journal:  Integr Med Res        ISSN: 2213-4220


× No keyword cloud information.
Gastroesophageal reflux disease (GERD) still remains one of the most common digestive disorder in neonates and infants.1, 2 There are several non-pharmacological and pharmacological therapies for GERD, however, most of them have limited efficacy, also the long-term use of antacids and proton pump inhibitors have some side-effects including diarrhea, constipation, headache and nausea. Consequently, there is a growing trend towards using complementary and alternative medicine worldwide. The aim of this study was to the effect of mastic oil massage on treatment of GERD in infants according to “The Canon of Medicine”. A total of 90 infant aged between one months to one year were included in the present study, diagnosis by a pediatric gastroenterologist according to GERD Symptom Questionnaire-Infant (GSQ-I) during the last seven days.5, 6 The participants were assigned into two groups of 45 patients using the block randomization method. The experimental group received omeprazole (20 mg/12 h) and abdominal massage with mastic gum oil (every 12 h), while control group received omeprazole capsules (20 mg/12 h) and abdominal massage without oil (every 12 h) for 2 weeks. The mother or nurse performed the abdominal massage clockwise around the navel and stomach for 10 min, approximately half an hour after the infant was fed (with milk or other food). The outcome measures were regurgitation and irritability, arching back and withdrawal, choking/gagging, and refusal to feed. Data were collected using the Global Severity Questionnaire (GSQ), which assesses the severity and frequency of each of the most common symptoms by age in the past 7 days, before and 1, 2 and 4 weeks. Data were analyzed in SPSS Statistics for Windows, version 16.0. Comparative tests such as the repeated measures analysis and ANOVA were employed to compare treatment outcomes in different weeks of intervention. Of fifty-four girls and thirty-six boys participated in this study and seventy-three participants completed the study. Eight patients in experimental group were discontinued the intervention because of side effects including skin allergy (6), restlessness (1), and diarrhea (1), while nine participants were excluded from analysis not regular participation of abdominal massage. There were no statistical differences between two groups in age, gender, and gastrointestinal complication in the mother (Supplement 1). In both groups, the mean composite symptoms score (CSS) decreased significantly over time without a statistically significant difference between the groups (Table 1). In both groups, the individual symptom score (ISS) values decreased during the two weeks of treatment. ISS and CSS increased in the first and fourth weeks of follow-up but did not reach baseline levels. This can be due to the short course of treatment, and we need to increase the treatment period.
Table 1

Change in CSS, ISS: at Baseline, 1 and 2 Weeks after Treatment, 1 and 4 Weeks’ Follow-up.

OutcomesBaseline1 week2 weeks1 week follow-up4 weeks follow-up
CSS scores
 Massage with oil64.91 ± 42.1033.38 ± 24.1424.16 ± 23.1032.54 ± 24.2933.24 ± 24.10
 Massage only51.64 ± 28.2541.78 ± 25.8837.83 ± 26.5638.50 ± 27.5638.39 ± 27.73
Regurgitation (ISS)
 Massage with oil10.82 ± 11.245.97 ± 7.704.27 ± 7.225.86 ± 7.676.13 ± 7.63
 Massage only9.31 ± 11.807.24 ± 8.896.52 ± 8.896.77 ± 10.146.91 ± 10.56
Irritability/fussiness (ISS)
 Massage with oil11.44 ± 10.175.81 ± 4.414.89 ± 5.006.18 ± 5.035.94 ± 5.06
 Massage only11.66 ± 1.218.56 ± 9.288.13 ± 9.528.58 ± 10.108.52 ± 10.08
Arching back (ISS)
 Massage with oil14.35 ± 12.456.91 ± 6.714.78 ± 6.096.48 ± 6.686.51 ± 6.66
 Massage only10.00 ± 8.388.18 ± 7.600.61 ± 7.757.30 ± 6.727.25 ± 6.69
Choking/gaging (ISS)
 Massage with oil7.17 ± 8.043.78 ± 5.952.40 ± 4.593.67 ± 5.753.67 ± 5.75
 Massage only5.44 ± 6.074.45 ± 5.734.11 ± 5.804.16 ± 5.824.16 ± 5.82
Refusal to feed (ISS)
 Massage with oil11.35 ± 9.856.16 ± 6.274.40 ± 5.705.89 ± 6.276.18 ± 6.27
 Massage only7.57 ± 5.046.48 ± 4.596.11 ± 4.796.25 ± 4.866.11 ± 4.67
Episodes of hiccup (ISS)
 Massage with oil9.35 ± 11.604.78 ± 6.923.62 ± 5.924.48 ± 6.744.54 ± 6.76
 Massage only7.66 ± 9.666.56 ± 10.095.02 ± 9.005.16 ± 8.985.16 ± 8.98

CSS: Composite Symptom Score, the sum of the ISS values; ISS: Individual Symptom Score, the score from multiplying the severity and the frequency of each symptom.

Change in CSS, ISS: at Baseline, 1 and 2 Weeks after Treatment, 1 and 4 Weeks’ Follow-up. CSS: Composite Symptom Score, the sum of the ISS values; ISS: Individual Symptom Score, the score from multiplying the severity and the frequency of each symptom. In this study, ISS and CSS, as two measures of the reflux symptoms, reduced in the both groups after treatment, indicating that the treatment was effective in both groups. However, there were no significant difference between the two groups. The abdominal massage with mastic oil may not be more effective than massage only. However, more extensive studies with larger sample sizes and longer treatment durations are recommended.

Author contribution

HMK, and MA conceptualized this study. MS, HMK, conducted this study. AGH, ZR, and SHN drafted the manuscript. MA, NKH, HMK critically commented on the manuscript and contributed to the revision. All authors approved the final version of this manuscript.

Conflict of interest

There are no conflicts of interest to declare.

Funding

No external funding was received.

Ethical statement

This study was approved by the Iran University of Medical Sciences (Code of Ethics: IR. IUMS.REC1396.9421309001) and is registered in the Iranian Registry of Clinical Trials (identifier: IRCT20180406039204N1).

Data availability

We added the basic characteristics of infant in Supplement 1. The raw data was provided by Supplement 2. Another data will be available upon request.
  5 in total

1.  Age-specific questionnaires distinguish GERD symptom frequency and severity in infants and young children: development and initial validation.

Authors:  Linda Deal; Benjamin D Gold; David A Gremse; Harland S Winter; Suzanne B Peters; Polly D Fraga; Michael E Mack; Stefanie M Gaylord; Vasundhara Tolia; Joseph F Fitzgerald
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-08       Impact factor: 2.839

2.  Effects of Quince syrup on clinical symptoms of children with symptomatic gastroesophageal reflux disease: A double-blind randomized controlled clinical trial.

Authors:  Mohammad Ebrahim Zohalinezhad; Mohammad Hadi Imanieh; Soliman Mohammadi Samani; Abdolali Mohagheghzadeh; Seyed Mohsen Dehghani; Mahmoud Haghighat; Alireza Salehi; Pouya Faridi; Amin Reza Akbarzadeh
Journal:  Complement Ther Clin Pract       Date:  2015-09-25       Impact factor: 2.446

Review 3.  Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review.

Authors:  Shlomi Cohen; Mirjam Bueno de Mesquita; Francis B Mimouni
Journal:  Br J Clin Pharmacol       Date:  2015-06-11       Impact factor: 4.335

Review 4.  Systematic review: questionnaires for assessment of gastroesophageal reflux disease.

Authors:  E A Bolier; B F Kessing; A J Smout; A J Bredenoord
Journal:  Dis Esophagus       Date:  2013-12-18       Impact factor: 3.429

Review 5.  Diagnosis and Management of Gastroesophageal Reflux Disease in Infants and Children: from Guidelines to Clinical Practice.

Authors:  Jeaneth Indira Gonzalez Ayerbe; Bruno Hauser; Silvia Salvatore; Yvan Vandenplas
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2019-03-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.